. 2024 Oct 2;10(6):e70004. doi: 10.1002/2056-4538.70004

Table 1.

Details of cohort

Clinical characteristics		AJMC (n = 197)			HUMC (n = 145)			CNUH (n = 397)			INHA (n = 129)
Clinical characteristics		EGFR wild‐type (n = 69)	EGFR mutant (n = 128)	p	EGFR wild‐type (n = 80)	EGFR mutant (n = 65)	p	EGFR wild‐type (n = 235)	EGFR mutant (n = 162)	p	EGFR wild‐type (n = 67)	EGFR mutant (n = 62)	p
Gender	Female	26	85	0.0001	29	41	0.0023	85	104	0.0001	24	45	0.0001
Gender	Male	43	43	0.0001	51	24	0.0023	150	58	0.0001	43	17	0.0001
Smoking status	Y	52	107	0.2272	53	53	0.0605	97	92	0.0032	32	51	0.0001
Smoking status	N	17	21	0.2272	27	12	0.0605	128	70	0.0032	35	11	0.0001
Family history	Y	66	126	0.477	74	59	0.736	209	128	0.0101	49	46	0.9493
Family history	N	3	2	0.477	5	6	0.736	26	34	0.0101	18	16	0.9493
Age (mean)		66.09 ± 9.94	64.10 ± 9.78	0.0941	65.15 ± 11.07	66.34 ± 12.51	0.3934	67.19 ± 9.34	66.37 ± 9.433	0.1505	63.17 ± 10.94	62.98 ± 12.01	0.4727
Height (mean)		162.69 ± 8.09	158.78 ± 9.15	0.0007	161.40 ± 8.51	159.21 ± 7.33	0.0404	162.01 ± 8.73	158.65 ± 8.28	0.0001	163.17 ± 7.07	157.89 ± 7.85	0.0003
Weight (mean)		62.85 ± 10.68	59.37 ± 10.93	0.0195	62.84 ± 10.67	59.58 ± 9.51	0.0334	64.50 ± 10.32	60.77 ± 10.24	0.0001	65.04 ± 11.64	62.23 ± 9.39	0.1813
Stage	I	44	101	0.0832	46	41	0.2866	189	133	0.3522	41	46	0.2664
	II	11	14		7	7		26	18		8	8
	III	11	8		12	12		10	2		16	7
	IV	3	5		15	5		10	9		2	1

The clinicopathological characteristics of cohorts of lung adenocarcinoma patients collected from four institutions, AJMC, HUMC, CNUH, and INHA, are summarized according to EGFR mutations. The statistical significance of differences between groups was evaluated by the chi‐square test or t‐test.